← All Sponsors
SPONSOR

Amgen

Total Trials
4
Recruiting
4
Phases
Phase 4, Phase 3, Phase 2
Conditions studied: Antineutrophil Cytoplasmic Antibody-associated VasculitisAtherosclerotic Cardiovascular DiseaseOverweightObesityObstructive Sleep ApneaSystemic Lupus ErythematosusActive Refractory Rheumatoid Arthritis
NCT06072482 Phase 4
Recruiting

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

Antineutrophil Cytoplasmic Antibody-associated Vasculitis
United States, Czechia, Hungary View Trial →
NCT07037433 Phase 3
Recruiting

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Atherosclerotic Cardiovascular Disease
United States, Argentina, Australia View Trial →
NCT07225686 Phase 3
Recruiting

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

Obesity
United States, Australia, Canada View Trial →
NCT06570798 Phase 2
Recruiting

A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

Systemic Lupus Erythematosus
United States, Australia, Belgium View Trial →